Prelude Capital Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32,023
| Closed | -$595K | – | 989 |
|
|
2025
Q1 | $595K | Buy |
+32,023
| New | +$595K | 0.05% | 389 |
|
|
2020
Q2 | – | Sell |
-125
| Closed | -$2K | – | 1303 |
|
|
2020
Q1 | $2K | Sell |
125
-2,975
| -96% | -$47.6K | ﹤0.01% | 859 |
|
|
2019
Q4 | $50K | Buy |
+3,100
| New | +$50K | ﹤0.01% | 943 |
|
|
2019
Q2 | – | Sell |
-1,080
| Closed | -$79K | – | 1230 |
|
|
2019
Q1 | $79K | Buy |
+1,080
| New | +$79K | ﹤0.01% | 684 |
|
|
2018
Q4 | – | Sell |
-14,854
| Closed | -$1.48M | – | 1375 |
|
|
2018
Q3 | $1.48M | Sell |
14,854
-6,540
| -31% | -$653K | 0.09% | 166 |
|
|
2018
Q2 | $1.52M | Buy |
+21,394
| New | +$1.52M | 0.1% | 170 |
|